Posts Tagged ‘DIR’
No DIR Reform in CMS’ 2020 Final Drug Pricing Rule
Despite over 4,000 comments from pharmacists and organizations like Currus, NCPA, the National Association of Chain Drug Stores (NACDS), and others across the country encouraging change, CMS elected not to address DIR reform in their final 2020 drug pricing rule released on Thursday. CMS said in a statement that they “will continue to carefully review…
Read MoreThousands Sign on in Support of DIR Proposal
According to NCPA, nearly 3,500 pharmacists and over 150 pharmacy stakeholder organizations have supported a potential change in DIR fees in the Centers for Medicare and Medicaid Services’ (CMS) proposed pricing rule for 2020. The proposed change would eliminate retroactive DIR fees and issue them at the point of sale. This move would save patients…
Read More